Sealing label
    1.
    发明授权
    Sealing label 有权
    密封标签

    公开(公告)号:US06746744B1

    公开(公告)日:2004-06-08

    申请号:US10049782

    申请日:2002-06-13

    IPC分类号: B32B310

    摘要: For sealing a container (2) consisting of a barrel portion (3) and a cap portion (4) threaded and tightened on the barrel portion, the sealing label (1) includes a lower portion (1A) for substantially wrapping the barrel portion and an upper portion (1B) for substantially wrapping the cap portion. The sealing label includes horizontal perforations (10) consisting of cut segments (11) and uncut segments (12; 13) extending along a border between the upper portion and the lower portion; a knob portion (1a) disposed at an edge of the upper portion; and inclined perforations (20) consisting of cut segments (21) and uncut segments (22) extending obliquely in the upper portion from the knob portion to the horizontal perforations.

    摘要翻译: 为了密封由筒部分(3)和螺纹和紧固在筒体部分上的盖部分(4)组成的容器(2),密封标签(1)包括用于基本上包裹筒部的下部(1A) 用于基本上包裹盖部的上部(1B)。 密封标签包括由切割部分(11)和沿着上部和下部之间的边界延伸的未切割部分(12; 13)组成的水平穿孔(10) 设置在所述上​​部的边缘处的把手部分(1a) 以及由切口段(21)和未切割区段(22)构成的倾斜穿孔(20),其在上部从旋钮部分倾斜延伸到水平穿孔。

    Thiazine or thiomorpholine derivatives
    2.
    发明授权
    Thiazine or thiomorpholine derivatives 失效
    噻嗪或硫代吗啉衍生物

    公开(公告)号:US5556841A

    公开(公告)日:1996-09-17

    申请号:US378502

    申请日:1995-01-26

    CPC分类号: C07D279/12 Y02P20/55

    摘要: This invention relates to the compounds of the formula [I] which are useful for the treatment of cataracts, and the synthetic intermediates of the formula [II], ##STR1## wherein R.sup.1 is hydroxy which can be protected by a hydroxy protective group;R.sup.2 is lower alkyl;R.sup.3 is hydrogen, lower alkyl, hydroxy, which can be protected by a hydroxy protective group, or lower alkoxy, and the said lower alkyl can be substituted by hydroxy, which can be protected by a hydroxy protective group, amino or lower alkylamino;R.sup.4 is carboxy which can be converted into ester or amide; tetrazolyl; phosphono which can be converted into ester or amide; or sulfonyl which can be converted into ester or amide;R.sup.5 is cyano or lower alkoxy;A is alkylene;B is C.dbd.O, C.dbd.S or CH.sub.2, and is single bond or double bond.

    摘要翻译: 本发明涉及可用于治疗白内障的式[I]化合物和式[II]的合成中间体,其中R 1是羟基,其可以 被羟基保护基保护; R2是低级烷基; R3是氢,低级烷基,羟基,其可以被羟基保护基或低级烷氧基保护,所述低级烷基可以被可被羟基保护基,氨基或低级烷基氨基保护的羟基取代; R4是可以转化成酯或酰胺的羧基; 四唑基; 可以转化成酯或酰胺的膦酰基; 或可以转化为酯或酰胺的磺酰基; R5是氰基或低级烷氧基; A是亚烷基; B为C = O,C = S或CH 2,+ Z为单键或双键。

    Shock absorber
    8.
    发明授权
    Shock absorber 失效
    减震器

    公开(公告)号:US06472043B1

    公开(公告)日:2002-10-29

    申请号:US09482567

    申请日:2000-01-14

    IPC分类号: B32B312

    摘要: A shock absorber comprising a honeycomb block with a plurality of cylindrical cell arranged in parallel, wherein the strength of said honeycomb block to withstand the load in the cell axial direction is adjusted by a processed configuration of said cells.

    摘要翻译: 一种减震器,其特征在于,具有并排配置有多个圆筒状电池的蜂窝块,其特征在于,通过所述电池的处理结构来调节所述蜂窝块承受电池轴向负载的强度。

    1,3-dialkylurea derivatives having a hydroxyl group
    10.
    发明授权
    1,3-dialkylurea derivatives having a hydroxyl group 失效
    具有羟基的1,3-二烷基脲衍生物

    公开(公告)号:US5891912A

    公开(公告)日:1999-04-06

    申请号:US663239

    申请日:1996-07-15

    CPC分类号: C07C275/24 C07C2101/14

    摘要: The present invention related to compounds represented by the following formula (I) and salts thereof, ##STR1## wherein R.sup.1 and R.sup.4 each represents a carboxyl or a carboxyl which is converted into an ester, an amide or hydroxamic acid; R.sup.2 represents a lower alkyl or a phenyl-lower alkyl; R.sup.3 represents a hydrogen atom, a lower alkyl, an amino-lower alkyl, a lower alkylamino-lower alkyl, a hydroxy-lower alkyl, a mercapto-lower alkyl, a carboxy-lower alkyl, a lower alkoxycarbonyl-lower alkyl, an imidazolyl-lower alkyl, an indolyl-lower alkyl, a (substituted) phenyl group, a (substituted) phenyl-lower alkyl group, a (substituted) naphthyl group, or a (substituted) naphtyl-lower group. The compounds of the present invention have inhibitory effects on endopeptidase 24.11 and are useful as therapeutic agents for cardiovascular disease such as heart failure and hypertension, renal disease such as renal failure, gastroenteric disorder, such as diarrhea and hyperchlorhydria, endocrine and metabolic disease such as obesity, and autoimmune disease such as rheumatism, and as an analgesics for myosalgia and migraine.

    摘要翻译: PCT No.PCT / JP95 / 02236 Sec。 371日期:1996年7月15日 102(e)日期1996年7月15日PCT 1995年11月1日PCT PCT。 WO96 / 14293 PCT出版物 日期:1996年5月17日本发明涉及由下式(I)表示的化合物及其盐,其中R 1和R 4各自表示羧基或被转化为酯的羧基,酰胺或异羟肟基 酸; R2代表低级烷基或苯基 - 低级烷基; R3表示氢原子,低级烷基,氨基 - 低级烷基,低级烷基氨基 - 低级烷基,羟基 - 低级烷基,巯基 - 低级烷基,羧基 - 低级烷基,低级烷氧基羰基 - 低级烷基,咪唑基 - 低级烷基,吲哚基 - 低级烷基,(取代)苯基,(取代的)苯基 - 低级烷基,(取代的)萘基或(取代的)萘基 - 低级基。 本发明的化合物对内肽酶24.11具有抑制作用,可用作心血管疾病如心力衰竭和高血压,肾脏疾病如肾功能衰竭,胃肠疾病如腹泻和高氯酸盐,内分泌和代谢疾病如 肥胖症和自身免疫性疾病如风湿病,以及作为肌营养不良和偏头痛的止痛剂。